All Posts: Georgetown Lombardi
-
Tobacco Regulations Center Receives $20 Million for Tobacco Use Research
The Center for the Assessment of Tobacco Regulations (CAsToR) — a collaboration among Georgetown University, the University of Michigan, and the British Columbia (BC) Cancer Research Institute — recently received $20 million in funding to continue its research on the impact of tobacco regulations on tobacco use patterns and their downstream health effects.
Category: News Release
-
BellRinger 2023 Celebrates Community Dedicated to Ending Cancer
BellRinger’s second annual ride brought together nearly 1,000 riders, more than 400 volunteers and countless supporters, all committed to giving researchers at Georgetown University’s Lombardi Comprehensive Cancer Center the funding they need to prevent, treat and cure cancer.
Category: GUMC Stories
-
Lombardi Women Event Rallies Support for Breast Cancer Research
The 17th Annual Lombardi Women event brought together nearly 400 of the Washington area’s most influential women in support of Georgetown University’s Lombardi Comprehensive Cancer Center and its Nina Hyde Center for Breast Cancer Research.
Category: GUMC Stories
-
How 2 Sisters Found Their Home at Georgetown
This story features Mala Dass and Indra Dass, and is part of a Georgetown Faces, a storytelling series that celebrates the beloved figures, unsung heroes and dedicated Hoyas who make our campus special.
Category: GUMC Stories
-
Raskin Discusses Cancer Diagnosis and Cura Personalis at Annual Kovach Lecture
On September 26, U.S. Rep. Jamie Raskin came to Georgetown to discuss his cancer experiences and thank his treating physician, MedStar Georgetown University Hospital hematologist-oncologist Joseph L. Roswarski, MD, at the third annual Edward M. Kovach Cura Personalis Endowed Lecture.
Category: GUMC Stories
-
Routine Lung Screening Spots Aggressive Cancer Early, Allows Successful Treatment
The detection of an aggressive form of lung cancer in a patient treated by experts at Georgetown University’s Lombardi Comprehensive Cancer Center demonstrates the importance of routine screenings and a strong relationship between patients and their primary care physicians.
Category: GUMC Stories
-
Biology Behind New Drug Used to Treat Triple-Negative Breast Cancer Uncovered
How TTP488 (azeliragon), an experimental drug, impairs aggressive, triple-negative breast cancer from metastasizing has been uncovered at the cellular level, according to researchers at Georgetown University’s Lombardi Comprehensive Cancer Center.
Category: News Release
-
Research To Help Patients Make Informed Decisions About Breast MRI
While many people think that breast cancer screening and mammography are synonymous, Claire Conley, PhD, wants people to know that women who are at higher than average risk for breast cancer may also receive a breast MRI.
Category: GUMC Stories
-
Researchers Develop Method to Monitor Cancer Radiotherapy Effects at the Cellular Level
Using complex molecular tools, Georgetown Lombardi researchers have determined how to measure, in real time, the effect that radiation treatment for cancer can have at the cellular level on surrounding healthy tissue.
Category: News Release
-
Novel Research Shows Older Breast Cancer Survivors Experience Accelerated Aging, Worse Functional Outcomes
In a new multicenter study, researchers from Georgetown University’s Lombardi Comprehensive Cancer Center, the Medical College of Wisconsin (MCW), UCLA and several other leading cancer centers from across the nation examined whether cancer and its treatments accelerate aging.
Category: News Release